top of page

The Scientific Advisory Committee (SAC) consists of 3-5 renowned independent experts from relevant scientific fields and with experience related to AMR, vaccines, mAbs and mathematical modelling. Non-executive body that will provide independent expert advice and feedback to the Steering Committee and General Assembly. During selection process of SAC members, the missing expertise related to social sciences and aspects of evolutionary biology will be considered. 

Scientific Advisory Committee (SAC)

Icon_PrIMAVeRa_transparent_high_res_edit

Advisory Bodies

Prof Mark Woolhouse

 University of Edinburgh

Dr Mateusz Hasso-Agopsowicz

World Health Organization

Prof Mical Paul

Israel Institute of Technology

Dr Alessandro Cassini

Swiss Public Health Department and Lausanne University Hospital

Ethics Advisory Board (EAB)

An Ethics Advisory Board (EAB) has been established by the COMBINE Coordination Support Office (CSO). External members with animal and human research ethics expertise have been recruited to the board as a resource for advice and guidance to COMBINE and to AMR Accelerator projects as requested or required. The COMBINE EAB will provide support to PrIMAVeRa on questions related to ethics.

​

​

AMR Accelerator Communication Advisory Board (CAB)

The AMR Accelerator Communication Advisory Board (CAB) will provide support on communication and dissemination activities of PrIMAVeRa.

IMI AMR Accelerator_Slogan_square_RGB.png
efpia.png

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034420. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

EU_flag.png
imi_logo.png

This communication reflects the authors' view(s) and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

Join European Vaccine Initiative mailing list for updates on projects, training and funding opportunities

Thanks for submitting! You can unsubscribe at anytime.

  • LinkedIn
  • Twitter
  • YouTube

© 2024 European Vaccine Initiative. Designed by European Vaccine Initiative

EVI_Logo_White_Website_2020.png
bottom of page